Medicines / Dr. Reddys Laboratories / Kyprolis
KyprolisCarfilzomib
Kyprolis is marketed by Dr. Reddys Laboratories. 2 packs on NPPA's price list for July 2026, containing Carfilzomib.
- Packs listed
- 2
- Lowest MRP
- ₹22,184
- Per unit
- ₹22,184 to ₹44,367
- Price-controlled packs
- 0 of 2
- Dosage forms
- 1
Packs and prices
- ₹22,184Kyprolis 30 mg Injection 1Carfilzomib Injection 30 mg · ₹22,184 per injection
- ₹44,367Kyprolis 60 mg Injection 1Carfilzomib Injection 60 mg · ₹44,367 per injection
The same composition from other brands
Packs with the identical filed composition, form and strength. A different brand is not automatically interchangeable: ask your doctor or pharmacist.
Carfilzomib Injection 60 mg
- ₹9,366/injectionCarfilnat · 1 injectionNatco Pharma · MRP ₹9,366
- ₹12,465/injectionCarfizome · 1 injectionIntas Pharmaceuticals · MRP ₹12,465
2 other brands of this composition on the price list; the 2 lowest per injection are shown. All Carfilzomib packs
The company
Dr. Reddys Laboratories has 1,399 packs on the price list, and CDSCO has named it as the manufacturer of 3 failed batches since May 2022. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.